Prosecution Insights
Last updated: October 02, 2026

Daegu Gyeongbuk Institute of Science and Technology

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

24 pending office actions • 14 art units • 24 examiners • 0 of 24 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days

Analysis

The Daegu Gyeongbuk Institute of Science and Technology manages 24 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 24 actions are assigned to 24 distinct examiners, resulting in a unique examiner for every single pending matter. This total lack of examiner overlap across 24 cases means that the institute must adapt its prosecution tactics to 24 different individual perspectives. SEBASTIAN, KAITLYN E is the busiest examiner, although she currently handles only 1 pending action.

The institute's prosecution is spread across 14 distinct art units, reflecting a diverse array of medical and mechanical innovations. With 24 pending office actions and 14 distinct art units, the portfolio is subject to a wide range of technical scrutiny. Because SEBASTIAN, KAITLYN E and all other examiners only have 1 pending action each, the institute's success depends on 24 independent negotiations. Practitioners should note that the high number of 14 art units relative to 24 actions suggests that the institute's research spans many different specialized niches within the medical device field. Maintaining a cohesive legal strategy across 14 art units and 24 examiners is the primary challenge for this portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

24
Total Pending OAs
16
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (50%)
11
Medium (46%)
1
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (17%)
§103 only10 (42%)
§102 only1 (4%)
§112 only1 (4%)
Multi-statute (no §101)8 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
29% of docket
1
Information Tech
4% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
9
Mechanical / Eng
38% of docket
7
Business / Other
29% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SEBASTIAN, KAITLYN E 1 73.8% +20.4%
MINCHELLA, ADAM ZACHARY 1 64.1% +33.9%
ANTISKAY, BRIAN MICHAEL 1 67.2% +39.3%
MCCARTY, PATRICK M 1 62.3% +23.0%
NGUYEN, HENRY H 1 63.7% +37.2%
RESTO OQUENDO, NATHALY MARIE 1 — —
WALLS, CYNTHIA KYUNG SOO 1 71.6% -0.8%
OSTROW, ALAN LINDSAY 1 73.1% +24.1%
VISCARRA, RICARDO I 1 62.8% +14.0%
RUSERE, LINAH NATSAI 1 — —

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18442544 WORK SPACE FORCE/ACCELERATION DISTURBANCE OBSERVER AND ROBOT INCLUDING THE SAME OSTROW, ALAN LINDSAY 149d overdue
17439124 CYTOKINE-BASED IMMUNE CELLS AND IMMUNOTHERAPEUTIC USE THEREOF SUNSHINE, HANNAH LOUISE 59d overdue
18207316 APPARATUS AND METHOD FOR RECONSTRUCTING HIGH-FREQUENCY BIO-SIGNAL BASED ON NEURAL NETWORK MODEL CATINA, MICHAEL ANTHONY 30d overdue
18446885 SIMULATOR AND SIMULATION SYSTEM FOR BRAIN TRAINING BASED ON BEHAVIOR MODELING GRANT, MICHAEL CHRISTOPHER 9d
18031314 THREE-DIMENSIONAL RETINAL STIMULATION DEVICE BERTRAM, ERIC D 23d
19150466 OPTICAL DUAL BRAIN SIGNAL MEASUREMENT DEVICE SEBASTIAN, KAITLYN E —
18845576 NEURAL INTERFACE AND METHOD FOR MANUFACTURING SAME MINCHELLA, ADAM ZACHARY —
18718600 BIOLOGICAL MATERIAL CONVEYOR DEVICE NGUYEN, HENRY H —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18442544 WORK SPACE FORCE/ACCELERATION DISTURBANCE OBSERVER AND ROBOT INCLUDING THE SAME OSTROW, ALAN LINDSAY 149d overdue
18442344 TASK SPACE OUTER-LOOP INTEGRATED DISTURBANCE OBSERVER AND ROBOT INCLUDING THE SAME VISCARRA, RICARDO I 8d overdue
19150466 OPTICAL DUAL BRAIN SIGNAL MEASUREMENT DEVICE SEBASTIAN, KAITLYN E —
18845576 NEURAL INTERFACE AND METHOD FOR MANUFACTURING SAME MINCHELLA, ADAM ZACHARY —
18726000 BIOELECTRODE HAVING IMPROVED MECHANICAL AND CHEMICAL DURABILITY AND METHOD FOR MANUFACTURING SAME ANTISKAY, BRIAN MICHAEL —
18574141 AMPHOTERIC ION EXCHANGE SEPARATOR FOR REDOX BATTERY, METHOD FOR MANUFACTURING SAME, AND REDOX BATTERY COMPRISING SAME MCCARTY, PATRICK M —
18718600 BIOLOGICAL MATERIAL CONVEYOR DEVICE NGUYEN, HENRY H —

Top Art Units

Art UnitApps
3794 2
3657 2
1622 2
3797 1
1631 1
1635 1
3715 1
3771 1
1735 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19150466 OPTICAL DUAL BRAIN SIGNAL MEASUREMENT DEVICE SEBASTIAN, KAITLYN E 3797 §102§103 Non-Final OA — Pending Jul 23, 2025
18845576 NEURAL INTERFACE AND METHOD FOR MANUFACTURING SAME MINCHELLA, ADAM ZACHARY — §102§103§112 Non-Final OA — Pending Apr 24, 2025
18726000 BIOELECTRODE HAVING IMPROVED MECHANICAL AND CHEMICAL DURABILITY AND METHOD FOR MANUFACTURING SAME ANTISKAY, BRIAN MICHAEL 3794 §103 Final Rejection — Pending Jul 01, 2024
18574141 AMPHOTERIC ION EXCHANGE SEPARATOR FOR REDOX BATTERY, METHOD FOR MANUFACTURING SAME, AND REDOX BATTERY COMPRISING SAME MCCARTY, PATRICK M — §103 Non-Final OA — Pending Jun 28, 2024
18718600 BIOLOGICAL MATERIAL CONVEYOR DEVICE NGUYEN, HENRY H — §103§112 Non-Final OA — Pending Jun 11, 2024
18702074 Lithium Secondary Battery RESTO OQUENDO, NATHALY MARIE — §103 Non-Final OA — Pending Apr 17, 2024
18686589 PEM FUEL CELL WALLS, CYNTHIA KYUNG SOO — §103 Non-Final OA — Pending Feb 26, 2024
18442544 WORK SPACE FORCE/ACCELERATION DISTURBANCE OBSERVER AND ROBOT INCLUDING THE SAME OSTROW, ALAN LINDSAY 3657 §101§102§112 Non-Final OA 149d overdue Pending Feb 15, 2024
18442344 TASK SPACE OUTER-LOOP INTEGRATED DISTURBANCE OBSERVER AND ROBOT INCLUDING THE SAME VISCARRA, RICARDO I 3657 §103 Final Rejection 8d overdue Pending Feb 15, 2024
18407959 ANODE AND LITHIUM BATTERY INCLUDING THE SAME RUSERE, LINAH NATSAI — §103 Non-Final OA — Pending Jan 09, 2024
18566001 NOVEL PLURIPOTENT CELLS MIANO, JOSEPH PAUL 1631 §102 Final Rejection 40d Pending Nov 30, 2023
18518727 PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF PROTAC, INCLUDING IU1-SERIES UBIQUITIN-SPECIFIC PROTEASE 14 INHIBITOR AS ACTIVE INGREDIENT ELENISTE, PIERRE PAUL 1622 §103 Non-Final OA — Pending Nov 24, 2023
18488479 NOVEL NICKEL FOAM HAVING HIERARCHICAL PORE STRUCTURE, METHOD OF PRODUCING THE SAME, AND APPLICATION THEREOF JEBUTU, MOFOLUWASO SIMILOLUWA — §102§103 Non-Final OA — Pending Oct 17, 2023
18287048 USE OF ODORANT RECEPTOR FOR SUPPRESSING LACTATE-INDUCED M2-TYPE DIFFERENTIATION OF TUMOR-ASSOCIATED MACROPHAGES AND TUMOR GROWTH GIBBS, TERRA C 1635 §101§112 Non-Final OA — Pending Oct 16, 2023
18446885 SIMULATOR AND SIMULATION SYSTEM FOR BRAIN TRAINING BASED ON BEHAVIOR MODELING GRANT, MICHAEL CHRISTOPHER 3715 §101§103 Non-Final OA 9d Pending Aug 09, 2023
18446036 STEERABLE AND EXPANDABLE ASPIRATION CATHETER HOLWERDA, KATHLEEN SONNETT 3771 §103 Non-Final OA 33d Pending Aug 08, 2023
18366025 POROUS TiO2-x-BASED CATALYST GROWN IN SITU AND METHOD OF PREPARING THE SAME SIMKINS, SLONE ELIZABETH 1735 §103§112 Non-Final OA — Pending Aug 07, 2023
18207316 APPARATUS AND METHOD FOR RECONSTRUCTING HIGH-FREQUENCY BIO-SIGNAL BASED ON NEURAL NETWORK MODEL CATINA, MICHAEL ANTHONY 3791 §101§112 Final Rejection 30d overdue Pending Jun 08, 2023
17780851 COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASES CAUSED BY GENETIC MUTATION COMPRISING FERULIC ACID AND ANALOGS THEREOF SOROUSH, LAYLA 1622 §102§103 Final Rejection — Pending May 24, 2023
18037549 CORONAVIRUS INFECTIOUS DISEASE COVID-19 THERAPEUTIC PROTEINS CTP ALPHA, CTP BETA, CTP GAMMA, CTP DELTA, AND USES THEREOF BEANE, RANDALL L 1654 §112 Non-Final OA — Pending May 17, 2023
18031314 THREE-DIMENSIONAL RETINAL STIMULATION DEVICE BERTRAM, ERIC D 3796 §102§103 Final Rejection 23d Pending Apr 11, 2023
17888836 APPARATUS AND METHOD WITH HOMOMORPHIC ENCRYPTION MAHMOUDI, RODMAN ALEXANDER 2499 §103 Final Rejection — Pending Aug 16, 2022
17525590 STRETCHABLE NANO-MESH BIOELECTRODE AND METHOD OF FABRICATING THE SAME PREMRAJ, CATHERINE C 3794 §103 Final Rejection — Pending Nov 12, 2021
17439124 CYTOKINE-BASED IMMUNE CELLS AND IMMUNOTHERAPEUTIC USE THEREOF SUNSHINE, HANNAH LOUISE 1647 §103§112 Non-Final OA 59d overdue Pending Sep 14, 2021

Managing Daegu Gyeongbuk Institute of Science and Technology's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month